TCRT-PGEN Fundamental & Technical Discussion Board - The UK-based company thatís striving to overcome the limitations of T cell receptor innovation - TCRT-PGEN Fundamental & Technical Discussion Board - InvestorVillage


TCRT-PGEN Fundamental & Technical Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: TCRT-PGEN Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  27768 of 28474  at  5/25/2022 9:03:14 PM  by

Bohsie


 In response to msg 27763 by  dnmun
view thread

Re: The UK-based company thatís striving to overcome the limitations of T cell receptor innovation

Pretenders? I can think of a few, one of which can just about copy and paste. Pretty sad and pathetic really. Anyway, their partners are Illumina, Great Ormond Street Hospital, Imperial College London, National Cancer Centre Singapore and Zelluna Immunotherapy.

Dr. Michelle Teng [CEO, Co-founder], has 20 years of R&D experience working on a breadth of projects from lead discovery to translational medicine.

Dr. Jacob Hurst [CTO, Co-founder], has 25 years of bioinformatics experience spanning across translational medicine, HIV, TCR and antibody repertoire analytics.

Dr. Bent Jakobsen [Director], CEO of Accession Therapeutics and founded Immunocore as well as Adaptimmune.

Dr. John McCafferty [Scientific Advisor], Founder of Cambridge Antibody Technology with Drs. Sir Gregory Winter [Nobel laureate] and David Chiswell. He also founded Maxion Tx and IonTas.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
27769 Re: The UK-based company thatís striving to overcome the limitations of T cell receptor innovation Eatsmelts 9 5/25/2022 11:28:29 PM


Financial Market Data provided by
.
Loading...